These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
165 related items for PubMed ID: 14557637
1. Latent gene sequencing reveals familial relationships among Chinese Epstein-Barr virus strains and evidence for positive selection of A11 epitope changes. Midgley RS, Bell AI, McGeoch DJ, Rickinson AB. J Virol; 2003 Nov; 77(21):11517-30. PubMed ID: 14557637 [Abstract] [Full Text] [Related]
2. HLA-A11-restricted epitope polymorphism among Epstein-Barr virus strains in the highly HLA-A11-positive Chinese population: incidence and immunogenicity of variant epitope sequences. Midgley RS, Bell AI, Yao QY, Croom-Carter D, Hislop AD, Whitney BM, Chan AT, Johnson PJ, Rickinson AB. J Virol; 2003 Nov; 77(21):11507-16. PubMed ID: 14557636 [Abstract] [Full Text] [Related]
3. Epstein-Barr virus latent gene sequences as geographical markers of viral origin: unique EBNA3 gene signatures identify Japanese viruses as distinct members of the Asian virus family. Sawada A, Croom-Carter D, Kondo O, Yasui M, Koyama-Sato M, Inoue M, Kawa K, Rickinson AB, Tierney RJ. J Gen Virol; 2011 May; 92(Pt 5):1032-1043. PubMed ID: 21248177 [Abstract] [Full Text] [Related]
4. T cell responses and virus evolution: loss of HLA A11-restricted CTL epitopes in Epstein-Barr virus isolates from highly A11-positive populations by selective mutation of anchor residues. de Campos-Lima PO, Levitsky V, Brooks J, Lee SP, Hu LF, Rickinson AB, Masucci MG. J Exp Med; 1994 Apr 01; 179(4):1297-305. PubMed ID: 7511684 [Abstract] [Full Text] [Related]
5. Genome diversity of Epstein-Barr virus from multiple tumor types and normal infection. Palser AL, Grayson NE, White RE, Corton C, Correia S, Ba Abdullah MM, Watson SJ, Cotten M, Arrand JR, Murray PG, Allday MJ, Rickinson AB, Young LS, Farrell PJ, Kellam P. J Virol; 2015 May 01; 89(10):5222-37. PubMed ID: 25787276 [Abstract] [Full Text] [Related]
6. Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma: in vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells. Masucci MG, Zhang QJ, Gavioli R, De Campos-Lima PO, Murray RJ, Brooks J, Griffin H, Ploegh H, Rickinson AB. Int Immunol; 1992 Nov 01; 4(11):1283-92. PubMed ID: 1282031 [Abstract] [Full Text] [Related]
7. Widespread sequence variation in Epstein-Barr virus nuclear antigen 1 influences the antiviral T cell response. Bell MJ, Brennan R, Miles JJ, Moss DJ, Burrows JM, Burrows SR. J Infect Dis; 2008 Jun 01; 197(11):1594-7. PubMed ID: 18419576 [Abstract] [Full Text] [Related]
8. Analysis of latent T-cell epitopes in Epstein-Barr virus isolated from extranodal nasal-type natural killer/T-cell lymphoma in Taiwanese population. Chou CC, Tsao CF, Liao CK, You HL, Wang MC, Huang WT. Exp Mol Pathol; 2021 Feb 01; 118():104577. PubMed ID: 33242451 [Abstract] [Full Text] [Related]
9. The life span of major histocompatibility complex-peptide complexes influences the efficiency of presentation and immunogenicity of two class I-restricted cytotoxic T lymphocyte epitopes in the Epstein-Barr virus nuclear antigen 4. Levitsky V, Zhang QJ, Levitskaya J, Masucci MG. J Exp Med; 1996 Mar 01; 183(3):915-26. PubMed ID: 8642295 [Abstract] [Full Text] [Related]
10. Epstein-Barr Virus Nuclear Antigen 3 (EBNA3) Proteins Regulate EBNA2 Binding to Distinct RBPJ Genomic Sites. Wang A, Welch R, Zhao B, Ta T, Keleş S, Johannsen E. J Virol; 2015 Dec 30; 90(6):2906-19. PubMed ID: 26719268 [Abstract] [Full Text] [Related]
11. Epstein-Barr virus (EBV) nuclear antigen (EBNA)-4 mutation in EBV-associated malignancies in three different populations. Chu PG, Chang KL, Chen WG, Chen YY, Shibata D, Hayashi K, Bacchi C, Bacchi M, Weiss LM. Am J Pathol; 1999 Sep 30; 155(3):941-7. PubMed ID: 10487851 [Abstract] [Full Text] [Related]
12. Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes. Sample J, Young L, Martin B, Chatman T, Kieff E, Rickinson A, Kieff E. J Virol; 1990 Sep 30; 64(9):4084-92. PubMed ID: 2166806 [Abstract] [Full Text] [Related]
13. Heterogeneity of the Epstein-Barr Virus (EBV) Major Internal Repeat Reveals Evolutionary Mechanisms of EBV and a Functional Defect in the Prototype EBV Strain B95-8. Ba Abdullah MM, Palermo RD, Palser AL, Grayson NE, Kellam P, Correia S, Szymula A, White RE. J Virol; 2017 Dec 01; 91(23):. PubMed ID: 28904201 [Abstract] [Full Text] [Related]
14. Immunoinformatic Analysis Reveals Antigenic Heterogeneity of Epstein-Barr Virus Is Immune-Driven. Cirac A, Poirey R, Dieckmeyer M, Witter K, Delecluse HJ, Behrends U, Mautner J. Front Immunol; 2021 Dec 01; 12():796379. PubMed ID: 34975903 [Abstract] [Full Text] [Related]
15. Recognition of the Epstein-Barr virus-encoded nuclear antigens EBNA-4 and EBNA-6 by HLA-A11-restricted cytotoxic T lymphocytes: implications for down-regulation of HLA-A11 in Burkitt lymphoma. Gavioli R, De Campos-Lima PO, Kurilla MG, Kieff E, Klein G, Masucci MG. Proc Natl Acad Sci U S A; 1992 Jul 01; 89(13):5862-6. PubMed ID: 1321426 [Abstract] [Full Text] [Related]
16. Epstein-Barr virus isolates with the major HLA B35.01-restricted cytotoxic T lymphocyte epitope are prevalent in a highly B35.01-positive African population. Lee SP, Morgan S, Skinner J, Thomas WA, Jones SR, Sutton J, Khanna R, Whittle HC, Rickinson AB. Eur J Immunol; 1995 Jan 01; 25(1):102-10. PubMed ID: 7531142 [Abstract] [Full Text] [Related]
17. Identifying Patient-Specific Epstein-Barr Nuclear Antigen-1 Genetic Variation and Potential Autoreactive Targets Relevant to Multiple Sclerosis Pathogenesis. Tschochner M, Leary S, Cooper D, Strautins K, Chopra A, Clark H, Choo L, Dunn D, James I, Carroll WM, Kermode AG, Nolan D. PLoS One; 2016 Jan 01; 11(2):e0147567. PubMed ID: 26849221 [Abstract] [Full Text] [Related]
18. Multiple HLA A11-restricted cytotoxic T-lymphocyte epitopes of different immunogenicities in the Epstein-Barr virus-encoded nuclear antigen 4. Gavioli R, Kurilla MG, de Campos-Lima PO, Wallace LE, Dolcetti R, Murray RJ, Rickinson AB, Masucci MG. J Virol; 1993 Mar 01; 67(3):1572-8. PubMed ID: 7679748 [Abstract] [Full Text] [Related]
19. Conservation of Epstein-Barr virus cytotoxic T-cell epitopes in posttransplant lymphomas: implications for immune therapy. Tao Q, Yang J, Huang H, Swinnen LJ, Ambinder RF. Am J Pathol; 2002 May 01; 160(5):1839-45. PubMed ID: 12000735 [Abstract] [Full Text] [Related]
20. Cytotoxic T-lymphocyte responses to a polymorphic Epstein-Barr virus epitope identify healthy carriers with coresident viral strains. Brooks JM, Croom-Carter DS, Leese AM, Tierney RJ, Habeshaw G, Rickinson AB. J Virol; 2000 Feb 01; 74(4):1801-9. PubMed ID: 10644353 [Abstract] [Full Text] [Related] Page: [Next] [New Search]